Pathways to the future: A new machine learning predictive tool for lobular breast cancer
Our researchers have developed a new machine learning tool that could help doctors predict long term outcomes and treatment response for people with invasive lobular breast cancer. This could open up new treatment avenues and help avoid unnecessary chemo for some people with lobular breast cancer.
10 Dec 2024
Our top 5 research discoveries in 2024
Research is the key to stopping breast cancer in its tracks. This year, our scientists have made incredible progress, uncovering discoveries that could transform treatments and bring us closer to a future where everyone with breast cancer lives, and lives well. In this article, we share some of the biggest achievements of the year and what they mean for people affected by breast cancer.
09 Dec 2024
New ‘triplet therapy’ doubles progression-free survival in advanced breast cancer
A clinical trial, led by one of our scientists, has revealed the benefits of a powerful combination of 3 drugs for aggressive secondary breast cancer.
31 Oct 2024
Celebrating 20 years of our Generations Study
The Breast Cancer Now Generations Study is a landmark project investigating the causes of breast cancer. This year we’re marking the 20-year anniversary and celebrating the study's successes so far.
17 Sept 2024
Researchers identify new target for treating secondary breast cancer in the brain
Our scientists have identified a key factor driving the spread of oestrogen receptor (ER) positive breast cancer to the brain. They hope this could eventually lead to new, better treatments for people affected by this type of secondary breast cancer.
13 Jul 2024
Researchers identify what drives PARP inhibitor resistance in secondary breast cancer
Researchers at The Institute of Cancer Research, London, have increased our understanding of how cancer drugs called PARP inhibitors stop working in people with secondary breast cancer. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to better ways to treat the disease.
07 May 2024
Our researchers have discovered a new targeted immunotherapy approach
Funded by us, researchers have discovered a new type of immunotherapy that could stop breast cancer from growing and spreading. They found that targeting a protein called endosialin using a specific type of immunotherapy disrupts the tumour's blood supply. This can hinder its growth and spread. The researchers are developing this treatment further so that it can be tested in clinical trials.
28 Feb 2024
A potential new way to overcome fulvestrant resistance in secondary breast cancer
Scientists have furthered our understanding of how some secondary breast cancers can become resistant to the hormone therapy fulvestrant.
08 Feb 2024
Helping researchers understand people’s experience of bisphosphonates
Our Breast Cancer Voices have helped a team of researchers better understand how people feel about taking bisphosphonates for primary breast cancer. Our Voices use their diverse breast cancer experiences to create change and impact breast cancer work and research.
25 Jan 2024
Our top 5 research breakthroughs of 2023
Research is the key to stopping breast cancer in its tracks. And our scientists have been working hard throughout the year to better understand breast cancer. With this comes some amazing discoveries, from improving treatments to discovering new ways to predict breast cancer spreading.
21 Dec 2023
Potential new drug combination for ER-positive breast cancer
Our scientists have found a potential new way to treat secondary oestrogen receptor (ER) positive breast cancers that have become resistant to existing drugs.
30 Nov 2023
Our researchers receive a prestigious science award
This year, our scientists at the Institute of Cancer Research help the ICR bring in the Queen’s Anniversary Prize.
17 Nov 2023
Making a difference in secondary breast cancer - our top achievements
In the UK, an estimated 61,000 people are living with secondary breast cancer. And although secondary breast cancer can be treated, it currently can’t be cured. We've been funding research into secondary breast cancer for over 20 years. And we’re making progress. We believe that research holds the key to stopping secondary breast cancer in its tracks.
25 Sept 2023
Researchers discover that existing drugs could potentially benefit thousands more people
31 Jul 2023
Supporting women with diet and exercise after breast cancer treatment
Leading a healthy lifestyle after a breast cancer diagnosis and treatment can help with this. So, our researchers are looking at ways to better support women with this.
19 Jul 2023
Researchers develop AI model to predict risk of secondary breast cancer
Researchers have developed an artificial intelligence model that can predict if triple negative breast cancer will spread.
24 May 2023
Researchers discover a new way to help prevent secondary breast cancer in the lung
Our scientists have uncovered a way in which breast cancer cells ‘wake-up’ and form secondary tumours in the lungs.
13 Mar 2023
The future of breast cancer screening
Breast cancer screening is an important tool for early detection. But what does screening currently look like? And how could it be improved?
08 Mar 2023
What do we still need to learn about DCIS?
Ductal Carcinoma in Situ (DCIS) is an early form of breast cancer. With DCIS, cancer cells are present in the breast duct, but they can’t spread to the surrounding breast tissue.
28 Feb 2023
Highlights from the San Antonio Breast Cancer Symposium 2022
We’re reporting on the San Antonio Breast Cancer Symposium 2022, the largest breast cancer conference in the world. Edd, our research communications officer, attended the symposium. He shares his highlights of days 1 to 4.
16 Feb 2023